The assessment of proposed studies to be conducted in the Czech Republic is performed by the State Institute for Drug Control and by at least one Ethics Committee independently of each other. In their assessment, Ethics Committees focus, in particular, upon the consideration of ethical aspects of the study, the qualification of doctors, and the facilities of the site.
In compliance with Section 54 of Act No 378/2007 Coll. on Amendment to the Act on Pharmaceuticals and on Amendments to Other Acts, applications for opinions on multicentric clinical trials are also submitted to the following Multicentric Ethics Committees.
List of Ethics Committee established at healthcare facilities